XML 66 R34.htm IDEA: XBRL DOCUMENT
v3.20.1

Note M - Segment and Geographic Data (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Notes Tables |
Schedule of Segment Reporting Information, by Segment [Table Text Block] |
|  | Years Ended December 31, |
Sales |  |  |  |  |  |
Net Sales: |  | 2019 |  |  | 2018 |
Dental |  | $ | 8,336,901 |  |  | $ | 9,502,276 |
Medical |  |  | 37,600 |  |  |  | 119,800 |
Total net sales |  | $ | 8,374,501 |  |  | $ | 9,622,076 |
Operating Income (Loss): |  | 2019 |  |  | 2018 |
Dental |  | $ | 2,775,716 |  |  | $ | 1,373,178 |
Medical |  |  | (2,350,103 | ) |  |  | (2,611,231 | )
Corporate |  |  | (4,424,606 | ) |  |  | (6,761,282 | )
Total operating loss |  | $ | (3,998,993 | ) |  | $ | (7,999,335 | )
Depreciation and Amortization: |  | 2019 |  |  | 2018 |
Dental |  | $ | 15,793 |  |  | $ | 16,474 |
Medical |  |  | 8,392 |  |  |  | 24,492 |
Corporate |  |  | 76,323 |  |  |  | 840,319 |
Total depreciation and amortization |  | $ | 100,508 |  |  | $ | 881,285 |
Income (loss) before taxes and equity in earnings of affiliates: |  | 2019 |  |  | 2018 |
Dental |  | $ | 2,774,332 |  |  | $ | 1,363,662 |
Medical |  |  | (2,353,194 | ) |  |  | (2,704,630 | )
Corporate |  |  | (8,064,576 | ) |  |  | (6,658,152 | )
Total loss before taxes and equity in earnings of affiliate |  | $ | (7,643,438 | ) |  | $ | (7,999,120 | )
Total Assets |  | 2019 |  |  | 2018 |
Dental |  | $ | 5,008,324 |  |  | $ | 5,169,944 |
Medical |  |  | 590,727 |  |  |  | 328,208 |
Corporate |  |  | 957,238 |  |  |  | 902,816 |
Total loss before taxes and equity in earnings of affiliate |  | $ | 6,556,289 |  |  | $ | 6,400,968 |
Sales by Product and by Geographical Region [Table Text Block] |
Total Product Sales-Dental |  | 2019 |  |  | 2018 |
Domestic-US and Canada |  | $ | 4,512,904 |  |  | $ | 4,798,706 |
International Rest of World |  |  | 3,665,347 |  |  |  | 3,803,570 |
International-China |  |  | 158,650 |  |  |  | 900,000 |
Total Product Sales-Dental |  | $ | 8,336,901 |  |  | $ | 9,502,276 |
Total Product Sales-Medical |  |  |  |  |  |  |  |
Domestic-US and Canada |  | $ | 13,700 |  |  | $ | 32,500 |
International Rest of World |  |  | 23,900 |  |  |  | 87,300 |
International-China |  |  | - |  |  |  | - |
Total Product Sales-Medical |  | $ | 37,600 |  |  | $ | 119,800 |
Domestic-US and Canada |  | $ | 4,526,604 |  |  | $ | 4,831,206 |
International Rest of World |  |  | 3,689,247 |  |  |  | 3,890,870 |
International-China |  |  | 158,650 |  |  |  | 900,000 |
Total |  | $ | 8,374,501 |  |  | $ | 9,622,076 |

X
- Definition Entire disclosure of sales by product and by geographical region. + References No definition available. + Details
Name: | mlss_SalesByProductAndByGeographicalRegionTableTextBlock
Namespace Prefix: | mlss_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration